These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7640101)

  • 1. Comparative study of the dialysability of iobitridol and iohexol in the rat with impaired renal function.
    Dencausse A; Chambon C; Violas X; Bonnemain B
    Acta Radiol; 1995 Sep; 36(5):545-8. PubMed ID: 7640101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of radio contrast media on residual renal function in peritoneal dialysis patients--a prospective study.
    Dittrich E; Puttinger H; Schillinger M; Lang I; Stefenelli T; Hörl WH; Vychytil A
    Nephrol Dial Transplant; 2006 May; 21(5):1334-9. PubMed ID: 16046499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative toxic effects of iobitridol and iohexol on the kidney.
    Wasaki M; Kawamura H; Sugimoto J; Shimada M; Satoh Y; Tanaka E; Gemba M
    Invest Radiol; 1998 Jul; 33(7):393-400. PubMed ID: 9659591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of biodistribution and changes in density following administration of iobitridol in rabbits. A comparative study vs iohexol.
    Rouleau P; Alison D; Bertrand P; Benderbous S; Havard P; Chambon C
    Acta Radiol Suppl; 1996; 400():49-55. PubMed ID: 8619352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective, randomized trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterization.
    Vijayalakshmi K; Williams D; Wright RA; Hall JA; Harcombe AA; Linker NJ; Stewart MJ; Davies A; de Belder MA
    J Invasive Cardiol; 2004 Dec; 16(12):707-11. PubMed ID: 15596875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicologic profile of iobitridol, a new nonionic low-osmolality contrast medium.
    Donandieu AM; Idee JM; Doucet D; Legros A; Penati S; Nain-Dit-Ducret M; Marmion F; Bonnemain B
    Acta Radiol Suppl; 1996; 400():17-24. PubMed ID: 8619348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic profile of iobitridol.
    Dencausse A; Violas X; Feldman H; Havard P; Chambon C
    Acta Radiol Suppl; 1996; 400():25-34. PubMed ID: 8619349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Iobitridol, a new nonionic low-osmolality contrast agent, and iohexol. Impact on renal histology in the rat.
    Beaufils H; Idée JM; Berthommier C; Balut C; Bourbouze R; Nimier K; Chicandre-Jouanneau C; Bonnemain B
    Invest Radiol; 1995 Jan; 30(1):33-9. PubMed ID: 7759214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Validity of iohexol clearance in patients with chronic renal failure and normal renal function in comparison to (99m)Tc-DTPA-clearance].
    Wiendieck E; Hartung R; Fünfstück R; Keil E; Gottschild D; Stein G
    Dtsch Med Wochenschr; 2003 Jan; 128(3):76-80. PubMed ID: 12529836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transplacental passage and milk excretion of iobitridol.
    Bourrinet P; Dencausse A; Havard P; Violas X; Bonnemain B
    Invest Radiol; 1995 Mar; 30(3):156-8. PubMed ID: 7797413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iohexol clearance for GFR-determination in renal failure--single or multiple plasma sampling?
    Sterner G; Frennby B; Hultberg B; Almen T
    Nephrol Dial Transplant; 1996 Mar; 11(3):521-5. PubMed ID: 8671824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal toxicity mediated by glucose degradation products in a rat model of advanced renal failure.
    Müller-Krebs S; Kihm LP; Zeier B; Gross ML; Deppisch R; Wieslander A; Henle T; Penndorf I; Oh J; Reiser J; Nawroth PP; Zeier M; Schwenger V
    Eur J Clin Invest; 2008 May; 38(5):296-305. PubMed ID: 18346151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of iobitridol versus iohexol for contrast-enhanced CT of the head.
    Drouillard J; Froment JC; Frija G; Caille JM; Gandon Y; Clarisse J; Gaston A
    Acta Radiol Suppl; 1996; 400():56-61. PubMed ID: 8619353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis for elimination of the nonionic contrast medium iohexol after angiography in patients with impaired renal function.
    Moon SS; Bäck SE; Kurkus J; Nilsson-Ehle P
    Nephron; 1995; 70(4):430-7. PubMed ID: 7477648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural changes in the renal proximal tubular cells induced by iodinated contrast media.
    Tervahartiala P; Kivisaari L; Kivisaari R; Vehmas T; Virtanen I
    Nephron; 1997; 76(1):96-102. PubMed ID: 9171307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole body quantitative autoradiographic study of the biodistribution of iobitridol in rats.
    Bourrinet P; Dencausse A; Cochet P; Bromet-Petit M; Chambon C
    Invest Radiol; 1994 Dec; 29(12):1057-60. PubMed ID: 7721547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical testing of iopromide. 1st communication: pharmacological evaluation.
    Krause W; Press WR; Frenzel T
    Arzneimittelforschung; 1994 Oct; 44(10):1162-6. PubMed ID: 7529504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is dialysis indicated immediately after administration of iodinated contrast agents in patients on haemodialysis?
    Hamani A; Petitclerc T; Jacobs C; Deray G
    Nephrol Dial Transplant; 1998 Apr; 13(4):1051-2. PubMed ID: 9568886
    [No Abstract]   [Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.